The binding of bFGF and its receptor (FGFR) may activate the signaling pathways of MAPKs/ERKs and PI3K/AKT, which is correlated with tumor growth, migration, angiogenesis and lymphangiogenesis [4, 5]. Here, FGF2 is linked to neoplasm.